Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 1, 1996, Pages 165-171

  Van den Berg, Michiel ^a   Stehouwer, Coen D A ^a   Bierdrager, Edwin ^a   Rauwerda, Jan A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

atherosclerosis; gender; homocysteine; methionine; severity

Indexed keywords

HOMOCYSTEINE; METHIONINE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL FEATURE; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE ASSOCIATION; DISEASE SEVERITY; HOMOCYSTINURIA; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL ANALYSIS;

EID: 0030053145     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.1.165     Document Type: Article

References (31)

1. Balkau B, Vray M, Eschwege E. Epidemiology of peripheral arterial disease. J Cardiovasc Pharmacol. 1994:23(suppl 3):S8-S16.
2. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, MeCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-386.
3. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality. Circulation. 1990;82:1925-1931.
4. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol. 1992;45:529-542.
5. Vogt MT, Wolfson SK, Kuller LH. Segmental arterial disease in the lower extremities: correlates of disease and relationship to mortality. J Clin Epidemiol. 1993;46:1267-1276.
6. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GHJ, Bromberg IL, Cerone R, Fowler B, Grobe H, Schmidt H, Schweitzer L. The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet. 1985;37:1-31.
7. Boers GHJ, Smals AGH, Trijbels FJM, Fowler B, Bakkeren JAJM, Schoonderwaldt HC, Kleijer WJ, Kloppenborg PWC. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med. 1985;313:709-715.
8. Malinow MR, Kang SS, Taylor LM, Wong PKW, Coull B, Inahara T, Mukerjee D, Sexton G, Upson B. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation. 1989;79:1180-1188.
9. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149-1155.
10. Ueland PM, Refsum H, Brattström L. Plasma homocysteine and vascular disease. In: Francis RB Jr, ed. Atherosclerotic Vascular Disease, Hemostasis and Endothelial Function. New York, NY: Marcel Dekker Inc; 1992:183-236.
11. Kang SS, Wong PWK, Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr. 1992;12:279-298.
12. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877-881.
13. Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordrehaug JE. Serum total homocysteine and coronary heart disease. Int J Epidemiol. 1995;24:704-709.
14. Starkehaum G, Marian JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest. 1986;77:1370-1376.
15. Harker LA, ROSS R, Slichter SJ, Scott CR. Homocysteine-induced atherosclerosis: the role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976;58:731-741.
16. Tsai J-C, Perrella MA, Yoshizumi M, Hsieh C-M, Haber E, Schlegel R, Lee M-E. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA. 1994;91:6369-6373.
17. Fowkes FRG. The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol. 1988;17:248-254.
18. Rutherford RB, Flanigan DP, Gupta SK, Johnston KW, Karmody A, Whittemore AD, Baker JD, Ernst CB. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg. 1986;4:80-94.
19. te Poele-Pothoff MTWB, van den Berg M, Franken DG, Boers GHJ, Jakobs C, de Kroon IFI, Eskes TABK, Trijbels JMF, Blom HJ. Three different methods for the determination of total homocysteine in plasma. Ann Clin Biochem. 1995;32:218-220.
20. 6 plus folic acid therapy in patients with arteriosclerosis and hyperhomocysteinemia. J Vasc Surg. 1994;20:933-940.
21. Verhoef P, Hennekens CH, Malinow R, Kok FJ, Willet WC, Stampfer MJ. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke. 1994;25:1924-1930.
22. von Eckardstein A, Malinow MR, Upson B, Heinrich J, Schulte H, Schönfeld R, Kohler E, Assmann G. Effects of age, lipoproteins. and hemostatic parameters on the role of homocyst(c)inemia as a cardiovascular risk factor in men. Arterioscler Thromb. 1994;14:460-464.
23. van den Berg M, Boers GHJ, Franken DG, Blom HJ, van Kamp GJ, Jakobs C, Stehouwer CDA. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur J Clin invest. 1995;25:176-181.
24. Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults: the Atherosclerosis Risk in Communities Study. Circulation. 1993;87:1107-1113.
25. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH. Association between plasma homocysteine concentrations and cxtracranial carotid-artery stenosis. N Engl J Med. 1995;332:286-291.
26. Alfthan G, Pekkanen J, Jauhiainen M, Pitkäniemi J, Karvonen M, Tuomilehto J, Salonen JT, Ehnholm C. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 1994;106:9-19.
27. Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Ant J Clin Nutr: 1992;55:131-138.
28. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ. The effect of blood sample aging and food consumption on plasma total homocysteine levels. Clin Chem Acta. 1992;207:119-128.
29. Guttormsen AB, Schneede J, Fiskerstrand T, Ueland PM, Refsum HM. Plasma concentrations of homocysteine and other aminothiol compounds arc related to food intake in healthy human subjects. J Nutr. 1994;124:1934-1941.
30. Banerjee AK, Pearson J, Gilliland EL, Goss D, Lewis JD, Stirling Y, Meade TW. A six year prospective study of fibrogen and other risk factors associated with mortality in stable claudicants. Thromb Haemost. 1992;68:261-263.
31. Fowkes FGR, Lowe GDO, Housley E, Rattray A, Rumley A, Elton RA, MacGregor IR, Dawes J. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet. 1993;342:84-86.